Study to Evaluate the Efficacy and Safety of OxabactTM on Reduction of Urinary Oxalate in Primary Hyperoxaluria Patients
NCT00638703
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
43
Enrollment
INDUSTRY
Sponsor class
Conditions
Primary Hyperoxaluria
Interventions
BIOLOGICAL:
Oxalobacter formigenes
DRUG:
Placebo
Sponsor
OxThera